ATE412903T1 - Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten - Google Patents

Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten

Info

Publication number
ATE412903T1
ATE412903T1 AT04717062T AT04717062T ATE412903T1 AT E412903 T1 ATE412903 T1 AT E412903T1 AT 04717062 T AT04717062 T AT 04717062T AT 04717062 T AT04717062 T AT 04717062T AT E412903 T1 ATE412903 T1 AT E412903T1
Authority
AT
Austria
Prior art keywords
disorders
diseases
diagnostics
receptor
related diseases
Prior art date
Application number
AT04717062T
Other languages
English (en)
Inventor
Stefan Golz
Ulf Brueggemeier
Holger Summer
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE412903T1 publication Critical patent/ATE412903T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04717062T 2003-03-17 2004-03-04 Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten ATE412903T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03005467 2003-03-17

Publications (1)

Publication Number Publication Date
ATE412903T1 true ATE412903T1 (de) 2008-11-15

Family

ID=33016821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04717062T ATE412903T1 (de) 2003-03-17 2004-03-04 Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten

Country Status (6)

Country Link
US (1) US20060240436A1 (de)
EP (1) EP1606621B1 (de)
AT (1) ATE412903T1 (de)
DE (1) DE602004017439D1 (de)
ES (1) ES2314383T3 (de)
WO (1) WO2004082568A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1654545A2 (de) * 2003-08-08 2006-05-10 Genova Ltd. Mit herzkreislaufstörungen im zusammenhang stehende sezernierte polypeptidspezies
ATE510020T1 (de) * 2003-12-24 2011-06-15 G2 Inflammation Pty Ltd Transgenes nichtmenschliches säugetier mit einem polynukleotid, das für human-c5ar oder humanisiertes c5ar codiert
DK2718322T3 (en) 2011-06-06 2018-12-03 Novo Nordisk As THERAPEUTIC ANTIBODIES
EP3349773A4 (de) * 2015-09-14 2019-05-01 Cincinnati Children's Hospital Medical Center Verfahren und zusammensetzungen zur behandlung der gaucher-krankheit durch modulation des c5a-rezeptors
TW202140553A (zh) 2020-01-13 2021-11-01 美商威特拉公司 C5ar1抗體分子及其用途
KR20230142831A (ko) 2021-01-13 2023-10-11 비스테라, 인크. 인간화된 보체 5a 수용체 1 항체 및 이의 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614370A (en) * 1994-03-18 1997-03-25 Merck & Co., Inc. Assay to identify human C5a antagonists and agonists
US5861272A (en) * 1995-06-02 1999-01-19 Human Genome Sciences, Inc. C5A receptor
CN102050758A (zh) * 2000-09-14 2011-05-11 田边三菱制药株式会社 酰胺衍生物及其制备药物的用途

Also Published As

Publication number Publication date
EP1606621A2 (de) 2005-12-21
US20060240436A1 (en) 2006-10-26
WO2004082568A2 (en) 2004-09-30
DE602004017439D1 (de) 2008-12-11
EP1606621B1 (de) 2008-10-29
ES2314383T3 (es) 2009-03-16
WO2004082568A3 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
EP2017620A3 (de) Diagnostika und Therapeutika für mit Dipeptidyl-peptidase 1 (DPP1) assoziierten Krankheiten
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE412903T1 (de) Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten
WO2005103702A3 (en) Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2)
WO2005078117A3 (en) Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6)
ATE552503T1 (de) Ctgf als biomarker, therapeutisches und diagnostisches ziel
WO2004097358A3 (en) Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
WO2005050225A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84)
WO2005106488A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2)
ATE554393T1 (de) Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen
DE602004014261D1 (de) Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten
WO2005040211A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1)
WO2004080374A3 (en) Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
WO2005059546A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35)
DE602004013770D1 (de) Diagnostik- und therapie- verfahren von mit pils verbundenen krankheiten
ATE397751T1 (de) Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheiten
WO2005040825A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
WO2005103711A3 (en) Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1)
WO2004082571A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86)
WO2004106934A3 (en) Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
WO2004099248A3 (en) Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2)
WO2004104595A3 (en) Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd)
WO2005026719A3 (en) Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3)
WO2005040824A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24)
WO2005040790A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties